Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67051 - 67075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	FGFR3	2261	downregulated	rosiglitazone results in decreased expression of FGFR3 mRNA	4p16.3	A22609
Rosiglitazone	Approved Investigational	FGR	2268	upregulated	rosiglitazone results in increased expression of FGR mRNA	1p35.3	A20427
Rosiglitazone	Approved Investigational	FMO5	2330	downregulated	rosiglitazone results in decreased expression of FMO5 mRNA	1q21.1	A22609
Rosiglitazone	Approved Investigational	FN1	2335	downregulated	rosiglitazone results in decreased expression of FN1 mRNA	2q35	A24117
Rosiglitazone	Approved Investigational	FN1	2335	upregulated	rosiglitazone results in increased expression of FN1 mRNA	2q35	A10216 A23178
Rosiglitazone	Approved Investigational	FOSL1	8061	upregulated	rosiglitazone results in increased expression of FOSL1 mRNA	11q13.1	A20427
Rosiglitazone	Approved Investigational	FSTL1	11167	upregulated	rosiglitazone results in increased expression of FSTL1 mRNA	3q13.33	A22609
Rosiglitazone	Approved Investigational	FUOM	282969	downregulated	rosiglitazone results in decreased expression of FUOM mRNA	10q26.3	A22609
Rosiglitazone	Approved Investigational	FUT7	2529	downregulated	rosiglitazone results in decreased expression of FUT7 mRNA	9q34.3	A10216
Rosiglitazone	Approved Investigational	FXYD5	53827	upregulated	rosiglitazone results in increased expression of FXYD5 mRNA	19q13.12	A22609
Rosiglitazone	Approved Investigational	FYN	2534	downregulated	rosiglitazone results in decreased expression of FYN mRNA	6q21	A22609
Rosiglitazone	Approved Investigational	G0S2	50486	downregulated	rosiglitazone results in decreased expression of G0S2 mRNA	1q32.2	A22609
Rosiglitazone	Approved Investigational	G0S2	50486	upregulated	rosiglitazone results in increased expression of G0S2 mRNA	1q32.2	A24100
Rosiglitazone	Approved Investigational	G6PC	2538	downregulated	rosiglitazone results in decreased expression of G6PC mRNA	17q21.31	A22609
Rosiglitazone	Approved Investigational	GABARAPL1	23710	upregulated	rosiglitazone results in increased expression of GABARAPL1 mRNA	12p13.2	A10216 A20427
Rosiglitazone	Approved Investigational	GADD45A	1647	upregulated	rosiglitazone results in increased expression of GADD45A mRNA	1p31.3	A20427
Rosiglitazone	Approved Investigational	GAR1	54433	upregulated	rosiglitazone results in increased expression of GAR1 mRNA	4q25	A22609
Rosiglitazone	Approved Investigational	GBA3	57733	downregulated	rosiglitazone results in decreased expression of GBA3 mRNA	4p15.2	A22609
Rosiglitazone	Approved Investigational	GCHFR	2644	downregulated	rosiglitazone results in decreased expression of GCHFR mRNA	15q15.1	A22609
Rosiglitazone	Approved Investigational	GCLM	2730	upregulated	rosiglitazone results in increased expression of GCLM mRNA	1p22.1	A22609 A20427
Rosiglitazone	Approved Investigational	GDF15	9518	upregulated	rosiglitazone results in increased expression of GDF15 mRNA	19p13.11	A10216 A22609 A20427
Rosiglitazone	Approved Investigational	GNL3	26354	upregulated	rosiglitazone results in increased expression of GNL3 mRNA	3p21.1	A22609
Rosiglitazone	Approved Investigational	GOLGA8A	23015	downregulated	rosiglitazone results in decreased expression of GOLGA8A mRNA	15q14	A10216
Rosiglitazone	Approved Investigational	GOLIM4	27333	downregulated	rosiglitazone results in decreased expression of GOLIM4 mRNA	3q26.2	A20427
Rosiglitazone	Approved Investigational	GPAT3	84803	upregulated	rosiglitazone results in increased expression of GPAT3 mRNA	4q21.23	A20427

Displaying entries 67051 - 67075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability